» Articles » PMID: 27815038

Phenotypes in Obstructive Sleep Apnea: A Definition, Examples and Evolution of Approaches

Overview
Journal Sleep Med Rev
Date 2016 Nov 6
PMID 27815038
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Obstructive sleep apnea (OSA) is a complex and heterogeneous disorder and the apnea hypopnea index alone can not capture the diverse spectrum of the condition. Enhanced phenotyping can improve prognostication, patient selection for clinical trials, understanding of mechanisms, and personalized treatments. In OSA, multiple condition characteristics have been termed "phenotypes." To help classify patients into relevant prognostic and therapeutic categories, an OSA phenotype can be operationally defined as: "A category of patients with OSA distinguished from others by a single or combination of disease features, in relation to clinically meaningful attributes (symptoms, response to therapy, health outcomes, quality of life)." We review approaches to clinical phenotyping in OSA, citing examples of increasing analytic complexity. Although clinical feature based OSA phenotypes with significant prognostic and treatment implications have been identified (e.g., excessive daytime sleepiness OSA), many current categorizations lack association with meaningful outcomes. Recent work focused on pathophysiologic risk factors for OSA (e.g., arousal threshold, craniofacial morphology, chemoreflex sensitivity) appears to capture heterogeneity in OSA, but requires clinical validation. Lastly, we discuss the use of machine learning as a promising phenotyping strategy that can integrate multiple types of data (genomic, molecular, cellular, clinical) to identify unique, meaningful OSA phenotypes.

Citing Articles

Research progress on the clinical subtyping of obstructive sleep apnea hypopnea syndrome.

Gao L, Peng Y, Ouyang R Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(10):1582-1590.

PMID: 40074307 PMC: 11897973. DOI: 10.11817/j.issn.1672-7347.2024.240252.


The Influence of Serotonergic Signaling on Quality of Life, Depression, Insomnia, and Hypoxia in Obstructive Sleep Apnea Patients: Cross-Sectional Study.

Ditmer M, Gabryelska A, Turkiewicz S, Gajewski A, Bialasiewicz P, Chalubinski M J Clin Med. 2025; 14(2).

PMID: 39860451 PMC: 11766041. DOI: 10.3390/jcm14020445.


Polysomnographic Phenotype of Positional Obstructive Sleep Apnea.

Park J, Kim Y, Park I, Han S, Kang S, Lee K J Rhinol. 2025; 31(3):168-175.

PMID: 39744446 PMC: 11685914. DOI: 10.18787/jr.2024.00039.


The Great Controversy of Obstructive Sleep Apnea Treatment for Cardiovascular Risk Benefit: Advancing the Science Through Expert Consensus. An Official American Thoracic Society Workshop Report.

Cohen O, Kundel V, Barbe F, Peker Y, McEvoy D, Sanchez-de-la-Torre M Ann Am Thorac Soc. 2024; .

PMID: 39513996 PMC: 11708754. DOI: 10.1513/AnnalsATS.202409-981ST.


Adherence to CPAP Therapy in Obstructive Sleep Apnea: A Prospective Study on Quality of Life and Determinants of Use.

Milinovic K, Pavlinac Dodig I, Lusic Kalcina L, Pecotic R, Ivkovic N, Valic M Eur J Investig Health Psychol Educ. 2024; 14(9):2463-2475.

PMID: 39329831 PMC: 11431498. DOI: 10.3390/ejihpe14090163.


References
1.
Hierl T, Humpfner-Hierl H, Frerich B, Heisgen U, Bosse-Henck A, Hemprich A . Obstructive sleep apnoea syndrome: results and conclusions of a principal component analysis. J Craniomaxillofac Surg. 1997; 25(4):181-5. DOI: 10.1016/s1010-5182(97)80073-x. View

2.
Ye L, Pien G, Ratcliffe S, Bjornsdottir E, Arnardottir E, Pack A . The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J. 2014; 44(6):1600-7. PMC: 6675398. DOI: 10.1183/09031936.00032314. View

3.
Woodruff P, Modrek B, Choy D, Jia G, Abbas A, Ellwanger A . T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009; 180(5):388-95. PMC: 2742757. DOI: 10.1164/rccm.200903-0392OC. View

4.
Tarca A, Carey V, Chen X, Romero R, Draghici S . Machine learning and its applications to biology. PLoS Comput Biol. 2007; 3(6):e116. PMC: 1904382. DOI: 10.1371/journal.pcbi.0030116. View

5.
Eckert D, White D, Jordan A, Malhotra A, Wellman A . Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med. 2013; 188(8):996-1004. PMC: 3826282. DOI: 10.1164/rccm.201303-0448OC. View